首页> 美国卫生研究院文献>Blood Transfusion >Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany

【2h】

Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany

机译：Abo血液组是子宫内膜子宫内膜癌患者的风险或预后因素吗？德国回顾性分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

A relationship is known to exist between gastric and pancreatic cancers and ABO antigens, caused by various immune modulations related to the ABO blood group of the patient. A similar relationship with regard to gynaecological cancers remains controversial.

机译：已知一种关系存在于胃和胰腺癌和ABO抗原之间，由与患者的ABO血液组有关的各种免疫调制引起的。与妇科癌症相似的关系仍然存在争议。

著录项

期刊名称 Blood Transfusion
作者
Georgios Gitas; Louisa Proppe; Ibrahim Alkatout; Dimitrios Tsolakidis; Achim Rody; Christos Kotanidis; Sascha Baum;
展开▼
作者单位

展开▼
年(卷),期 2020(18),6
年度 2020
页码 465–470
总页数 6
原文格式 PDF
正文语种
中图分类血液学检验;
关键词
ABO blood group; endometrial cancer; risk factor; outcome; prognosis;

机译：abo血液组;子宫内膜癌;危险因素;结果;预后;

相似文献

外文文献
中文文献
专利

1. Prognostic significance of lymphovascular space invasion in patients with endometrioid endometrial cancer: a retrospective study from a single center [J] . Yibo Dai, Yangyang Dong, Yuan Cheng, Journal of Gynecologic Oncology . 2020,第3期

机译：子宫内膜子宫内膜癌患者淋巴血管空间侵袭的预后意义：单个中心的回顾性研究
2. Mismatch repair deficiency identifies patients with high‐intermediate–risk (HIR) endometrioid endometrial cancer at the highest risk of recurrence: A prognostic biomarker [J] . Backes Floor J., Haag Jennifer, Cosgrove Casey M., Cancer: A Journal of the American Cancer Society . 2019,第3期

机译：不匹配修复缺乏症识别高中风险（HIR）子宫内膜子宫内膜癌的患者，其在复发的最高风险：预后生物标志物
3. Mismatch Repair Deficiency Identifies Patients With High-Intermediate-Risk (HIR) Endometrioid Endometrial Cancer at the Highest Risk of Recurrence: A Prognostic Biomarker EDITORIAL COMMENT [J] . Van Le Linda Obstetrical and gynecological survey . 2019,第4期

机译：不匹配修复缺乏症识别高中间风险（HIR）子宫内膜子宫内膜癌的患者，其复发的最高风险：预后生物标志物编辑评论
4. Molecular Genetic Profiles of Serous and Endometrioid Endometrial Cancers, Genes Downregulated in Endometrial Cancers, and the Role of Epigenetics [C] . John I. Risinger, G. Larry Maxwell, Louis A. Dainty, International Symposium on the Cell and Molecular Biology of Endometrial Carcinoma . 2003

机译：None
5. Retrospective analysis of treatment-related risk of secondary malignancies among patients diagnosed and treated for childhood cancers at Cook Children's Medical Center [D] . Le, Phuong. 2011

机译：在库克儿童医学中心诊断和治疗儿童癌症的患者中与治疗相关的继发性恶性肿瘤风险的回顾性分析
6. Analysis of serum level of HE4 and CA125 considering selected risk factors among patients with endometrioid endometrial cancer [O] . Nabil Abdalla, Robert Piorkowski, Anna Slomka, 2016

机译：考虑子宫内膜样子宫内膜癌患者危险因素的HE4和CA125血清水平分析
7. Why do some patients with stage 1A and 1B endometrial endometrioid carcinoma experience recurrence? A retrospective study in search of prognostic factors [O] . Birol Ocak, Ahmet Bilgehan Sahin, Fatma Oz Atalay, 2021

机译：为什么一些患者1A阶段和1B子宫内膜内疗中的癌症经验复发？寻求预后因素的回顾性研究

Is ABO blood group a risk or prognostic factor for patients with endometrioid endometrial cancer? A retrospective analysis in Germany

摘要

著录项

相似文献

相关主题

期刊订阅